PBLS 8-K 2026-08-13

Parabilis Medicines, Inc. (PBLS) 8-K dated 2026-08-13 — accession 0001193125-26-347869.

Parabilis Medicines, Inc. (PBLS) common stock.

Parabilis Medicines, Inc. filed a 8-K on 2026-08-13. Accession 0001193125-26-347869.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PBLS revenue for 2026-06-30 was $148.0K. Net income was -$52.5M.

Not investment advice. The PBLS SEC hub lists recent forms. The stock page is the research view.